Protective Role of Superoxide Dismutase against Diabetogenic Drugs
AUTOR(ES)
Gandy, Samuel E.
RESUMO
Copper-zinc superoxide dismutase (SOD) is present in relatively high concentrations in the β-cells of human islets. The activity of the extracted enzyme is partially inhibited upon incubation with the diabetogenic drugs alloxan, streptozotocin, or Vacor. The role of this enzyme in protecting β-cells against chemically induced diabetes was further investigated.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=370268Documentos Relacionados
- Protective role of intracellular superoxide dismutase against extracellular oxidants in cultured rat gastric cells.
- The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice.
- Superoxide Dismutase: A POSSIBLE PROTECTIVE ENZYME AGAINST OZONE INJURY IN SNAP BEANS (PHASEOLUS VULGARIS L.)
- Protective effect of extracellular superoxide dismutase on endothelial function during aging
- Role of Mycobacterium tuberculosis Copper-Zinc Superoxide Dismutase